The hedgehog pathway in triple-negative breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Stem Cell Research

Background:

• Triple-negative breast cancer (TNBC) presents significant therapeutic challenges due to its heterogeneity and lack of targeted treatments.
• Breast cancer stem cells (BCSCs) are implicated in TNBC's aggressive nature and resistance to systemic therapies.
• The Hedgehog (Hh) signaling pathway is increasingly recognized for its role in stem cell renewal and cancer development.

Purpose of the Study:

• To review the evidence supporting a pathophysiological role of Hh signaling in TNBC.
• To explore the mechanisms of crosstalk between Hh signaling and other critical pathways in TNBC.
• To discuss the potential of Hh-targeted interventions for TNBC treatment.

Main Methods:

• Literature review of preclinical and clinical studies on Hh signaling in breast cancer.
• Analysis of signaling network interactions relevant to TNBC pathogenesis.
• Synthesis of current understanding of Hh pathway involvement in TNBC.

Main Results:

• Evidence suggests Hh signaling is active in TNBC and contributes to its pathogenesis.
• Hh pathway crosstalks with other key signaling networks, influencing TNBC progression.
• Understanding these interactions is crucial for developing effective targeted therapies.

Conclusions:

• The Hedgehog pathway is a promising therapeutic target for triple-negative breast cancer.
• Targeting Hh signaling, potentially in combination with other pathways, may overcome treatment resistance in TNBC.
• Further research into Hh pathway mechanisms and crosstalk is warranted for clinical translation.